During the past decade, Clinique Pasteur ONCORAD conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Pasteur ONCORAD" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Janssen Pharmaceutica" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Pasteur ONCORAD" are "Prostate Cancer" (1 trials) and "Prostate Cancer Metastatic" (1 trials). Many other conditions were trialed in "Clinique Pasteur ONCORAD" in a lesser frequency.

Most popular intervention types in "Clinique Pasteur ONCORAD" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Androgen deprivation therapy" (1 trials), "Apalutamide" (1 trials), "Darolutamide 300 mg" (1 trials), "Luteinising Hormone Releasing Hormone agonist (LHRHa)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Pasteur ONCORAD" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Pasteur ONCORAD". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinique Pasteur ONCORAD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Pasteur ONCORAD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".